Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01750242 · ClinicalTrials.gov registry record

Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study

A clinical trial of Parkinson's Disease, sponsored by MedtronicNeuro.

Completed
Registry status
20
Enrollment target
2
Study locations

NCT01750242 is a study of Parkinson's Disease that has completed, run by MedtronicNeuro. The registered enrollment target is 20 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01750242, a study of Parkinson's Disease, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

To evaluate DBS device settings and match with the features of the DBS care management software.

Conditions Studied

Parkinson's Disease

Interventions

  • DEVICE Medtronic DBS system

Study Locations (2)

California

  • Scripps Clinic, Division of Neurology - La Jolla

Kansas

  • Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-11
Est. Completion 2013-08

Sponsor

MedtronicNeuro

51 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01750242

The ClinicalTrials.gov registry entry for NCT01750242 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (97% lower). The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Medtronic DBS system is the first listed.

NCT01750242 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Kansas.

Frequently Asked Questions

What is clinical trial NCT01750242 about?

NCT01750242 is a clinical study titled "Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study". To evaluate DBS device settings and match with the features of the DBS care management software.

What is the current status of trial NCT01750242?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-11. Estimated completion is 2013-08.

What conditions does trial NCT01750242 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT01750242?

The interventions under investigation include: Medtronic DBS system (DEVICE).

Who is sponsoring clinical trial NCT01750242?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01750242 being conducted?

This trial has 2 study locations across California, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.